Monash IVF Group Limited (MVF.AX)

AUD 1.08

(3.86%)

Net Debt Summary of Monash IVF Group Limited

Monash IVF Group Limited's latest annual net debt in 2024 was 48.23 Million AUD , up 34.77% from previous year.
Monash IVF Group Limited's latest quarterly net debt in 2024 FY was 124.03 Million AUD , up 34.77% from previous quarter.
Monash IVF Group Limited reported annual net debt of 92.03 Million AUD in 2023, up 32.7% from previous year.
Monash IVF Group Limited reported annual net debt of 69.35 Million AUD in 2022, up 86.31% from previous year.
Monash IVF Group Limited reported quarterly net debt of 124.03 Million AUD for 2024 FY, up 34.77% from previous quarter.
Monash IVF Group Limited reported quarterly net debt of 115.81 Million AUD for 2024 Q2, up 25.84% from previous quarter.

Annual Net Debt Chart of Monash IVF Group Limited (2024 - 2013)

Historical Annual Net Debt of Monash IVF Group Limited (2024 - 2013)

Year	Net Debt	Net Debt Growth
2024	48.23 Million AUD	34.77%
2023	92.03 Million AUD	32.7%
2022	69.35 Million AUD	86.31%
2021	37.22 Million AUD	-12.41%
2020	42.5 Million AUD	-49.44%
2019	84.06 Million AUD	-10.81%
2018	94.25 Million AUD	2.27%
2017	92.16 Million AUD	6.51%
2016	86.52 Million AUD	-10.12%
2015	96.27 Million AUD	11.04%
2014	86.7 Million AUD	-64.37%
2013	243.35 Million AUD	0.0%

Year	Net Debt	Net Debt Growth
2024 Q4	48.23 Million AUD	7.1%
2024 FY	124.03 Million AUD	34.77%
2024 Q2	115.81 Million AUD	25.84%
2023 Q4	92.03 Million AUD	18.11%
2023 Q2	77.92 Million AUD	12.35%
2023 FY	92.03 Million AUD	32.7%
2022 Q4	69.35 Million AUD	78.87%
2022 Q2	38.77 Million AUD	4.16%
2022 FY	69.35 Million AUD	86.31%
2021 Q2	34.87 Million AUD	-17.95%
2021 Q4	37.22 Million AUD	6.76%
2021 FY	37.22 Million AUD	-12.41%
2020 FY	42.5 Million AUD	-49.44%
2020 Q2	112.34 Million AUD	33.63%
2020 Q4	42.5 Million AUD	-62.17%
2019 FY	84.06 Million AUD	-10.81%
2019 Q2	88.23 Million AUD	-5.87%
2019 Q4	84.06 Million AUD	-4.72%
2018 Q2	94.16 Million AUD	2.88%
2018 FY	94.25 Million AUD	2.27%
2018 Q4	93.74 Million AUD	-0.45%
2017 FY	92.16 Million AUD	6.51%
2017 Q4	91.53 Million AUD	-1.17%
2017 Q2	92.61 Million AUD	7.73%
2016 FY	86.52 Million AUD	-10.12%
2016 Q4	85.96 Million AUD	-8.09%
2016 Q2	93.53 Million AUD	-2.84%
2015 Q4	96.27 Million AUD	14.63%
2015 FY	96.27 Million AUD	11.04%
2015 Q2	83.98 Million AUD	-3.2%
2014 Q2	170.57 Million AUD	-29.9%
2014 FY	86.7 Million AUD	-64.37%
2014 Q4	86.75 Million AUD	-49.14%
2013 FY	243.35 Million AUD	0.0%
2013 Q4	243.35 Million AUD	0.0%

Peer Net Debt Comparison of Monash IVF Group Limited

Name	Net Debt	Net Debt Difference
Australian Clinical Labs Limited	282.76 Million AUD	82.943%
BCAL Diagnostics Limited	-5.83 Million AUD	927.073%
Genetic Signatures Limited	-35.03 Million AUD	237.684%
Genetic Technologies Limited	-377.06 Thousand AUD	12891.53%
Healius Limited	1.53 Billion AUD	96.864%
Imagion Biosystems Limited	5.81 Million AUD	-729.975%
Integral Diagnostics Limited	315.35 Million AUD	84.706%
INOVIQ Ltd	-8.69 Million AUD	654.51%
Microba Life Sciences Limited	-20.49 Million AUD	335.346%
Rhythm Biosciences Limited	-545.67 Thousand AUD	8938.977%
Sonic Healthcare Limited	3.87 Billion AUD	98.754%